ResoTher Pharma
Phase 2Biotechnology company on a mission to deliver new and effective treatment options for patients suffering from cardiovascular disease.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $15.2M
About
Biotechnology company on a mission to deliver new and effective treatment options for patients suffering from cardiovascular disease.
RNA & Gene Therapy
Funding History
2Total raised:$15.2M
Series A$12MMar 15, 2022
Seed$3.2MMay 15, 2020